Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Epirrubicina"'
Autor:
Vitale, Daiana Lujan
Publikováno v:
Repositorio Institucional (UNSAM)
Universidad Nacional de General San Martín
instacron:UNSAM
Universidad Nacional de General San Martín
instacron:UNSAM
Tesis de Doctorado en Biología Molecular y Biotecnología El desarrollo de resistencia a drogas durante la quimioterapia es una de las principales causas de recurrencia y mortalidad en cáncer. Las células tumorales modifican su microambiente (MAT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::66916c3e9e0e3e676702b7d688e56ce5
https://ri.unsam.edu.ar/handle/123456789/1963
https://ri.unsam.edu.ar/handle/123456789/1963
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Dissertação de Mestrado em Bioquímica apresentada à Faculdade de Ciências e Tecnologia Com o passar dos anos, as doenças cancerígenas tornaram-se um dos maiores e mais letais problemas de saúde em todo o mundo. No entanto, os tratamentos conv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c26f084a9c18395a016d38684e6ff8c7
Autor:
Alexsandra Eliane de Souza
Publikováno v:
Repositório Institucional da UFU
Universidade Federal de Uberlândia (UFU)
instacron:UFU
Universidade Federal de Uberlândia (UFU)
instacron:UFU
Esse trabalho consiste no estudo da interação entre o biopolímero quitosana e o quimioterápico epirrubicina através de analise de resultados de simulações efetuadas no programa GROMACS. A realização da revisão da literatura forneceu as base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0895ffa7e7f827815b53c00ce62a419b
https://doi.org/10.14393/ufu.di.2020.742
https://doi.org/10.14393/ufu.di.2020.742
Autor:
Terra, Mariana Durão
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::318483c09a4fa8edfc987add260c4bb1
Autor:
Miguel, Martín, Alvaro, Rodríguez-Lescure, Amparo, Ruiz, Emilio, Alba, Lourdes, Calvo, Manuel, Ruiz-Borrego, Blanca, Munárriz, César A, Rodríguez, Carmen, Crespo, Enrique, de Alava, José Antonio, López García-Asenjo, María Dolores, Guitián, Sergio, Almenar, Jesús Fernando, González-Palacios, Francisco, Vera, José, Palacios, Manuel, Ramos, Jose Manuel, Gracia Marco, Ana, Lluch, Isabel, Alvarez, Miguel Angel, Seguí, José Ignacio, Mayordomo, Antonio, Antón, José Manuel, Baena, Arrate, Plazaola, Alfonso, Modolell, Amadeu, Pelegrí, Jose Ramón, Mel, Enrique, Aranda, Encarna, Adrover, José Valero, Alvarez, José Luis, García Puche, Pedro, Sánchez-Rovira, Sonia, Gonzalez, José Manuel, López-Vega, M Francisca, Garijo
Publikováno v:
JNCI Journal of the National Cancer Institute. 100:805-814
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; BACKGROUND Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a consequence, the
Autor:
Giuseppe De Rosa, Michele Caraglia, Chiara Riganti, Vincenzo Desiderio, Sara Lusa, Dario Antonio Ghigo, Elena Gazzano, Antonio Giordano, Martha L. Pinzon-Daza, Giuseppina Salzano, Joanna Kopecka, Stefania Porto
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
Oncotarget
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
Oncotarget
The resistance to chemotherapy and the tumor escape from host immunosurveillance are the main causes of the failure of anthracycline-based regimens in breast cancer, where an effective chemo-immunosensitizing strategy is lacking. The clinically used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9542c71f17fec3a250c253aafc30e0
http://hdl.handle.net/11365/997445
http://hdl.handle.net/11365/997445
Autor:
Calian, Odilon Azevedo
Publikováno v:
Repositório Institucional da UFVUniversidade Federal de ViçosaUFV.
Made available in DSpace on 2015-03-26T13:47:16Z (GMT). No. of bitstreams: 1 texto completo.pdf: 1204854 bytes, checksum: 3444b450baa838c9ffdcfffb1cfd08bd (MD5) Previous issue date: 2013-07-05
Some drugs, such as doxorubicin, among other mechani
Some drugs, such as doxorubicin, among other mechani
Externí odkaz:
http://locus.ufv.br/handle/123456789/5151
Autor:
Calian, Odilon Azevedo
Publikováno v:
LOCUS Repositório Institucional da UFV
Universidade Federal de Viçosa (UFV)
instacron:UFV
Universidade Federal de Viçosa (UFV)
instacron:UFV
Some drugs, such as doxorubicin, among other mechanisms act by triggering apoptosis, which not only affects the tumor but also normal cells in the body. Therefore, the study of the side effects of chemotherapy, seeking a less aggressive treatment for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::bebf3285c88d65c045aa225c023eb0aa
http://locus.ufv.br/handle/123456789/5151
http://locus.ufv.br/handle/123456789/5151
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Dissertação de mestrado em Bioquimica apresentada ao Departamento Ciências da Vida da Faculdade de Ciências e Tecnologia da Universidade de Coimbra O cancro da mama é uma doença heterogénea e é a maior causa de morte por cancro entre as mulhe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::91386be857fd719314fb9acf22cfafea
Autor:
Maria Amalia Fernandez Feijoo, Ruth Ubago Pérez, Miguel Angel Calleja Hernández, Patricia Araque Arroyo
Publikováno v:
Journal of Cancer Research and Therapeutics. 6:573
Case Reports; Journal Article; A 75-year-old man diagnosed with lower esophageal adenocarcinoma suffered from epirubicin extravasation during the second cycle of neoadjuvant chemotherapy with epirubicin and oxaliplatin. A full recovery was achieved a